Work

Discovery of Covalently-bound, First-in-Class Allosteric Inhibitor of PRMT5

Year: 2020

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(20)31075-3

Authors: D. McKinney, M. Ranaghan, B. McMillan, M. Brousseau, M. O’Keefe, J. Moroco, R. Singh, B. Besnik, P. McCarren, K. Mulvaney, W. Sellers, A. Ianari

Institutions: Broad Institute, Tango Therapeutics (United States)

Language: English

Topic: Cancer-related gene regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3096897463

FWCI: 0.069

Cites:

Cited by: 1

Related to: 10